These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11917819)

  • 1. Redbook and PSA testing.
    Simpson H
    Aust Fam Physician; 2002 Feb; 31(2):120. PubMed ID: 11917819
    [No Abstract]   [Full Text] [Related]  

  • 2. The redbook and prostate cancer.
    Brett T
    Aust Fam Physician; 2002 Feb; 31(2):120-1. PubMed ID: 11917820
    [No Abstract]   [Full Text] [Related]  

  • 3. Measuring the importance of PSA velocity.
    Tuma RS
    J Natl Cancer Inst; 2011 Mar; 103(6):454-61. PubMed ID: 21393606
    [No Abstract]   [Full Text] [Related]  

  • 4. Why PSA testing does have value.
    Kirby M
    Practitioner; 1997 Jul; 241(1576):363. PubMed ID: 9425708
    [No Abstract]   [Full Text] [Related]  

  • 5. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
    Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.
    D'Amico AV
    J Clin Oncol; 2008 Feb; 26(6):823-4. PubMed ID: 18281649
    [No Abstract]   [Full Text] [Related]  

  • 7. PSA level changes over time in men with an initial PSA level of < or = 4 ng/ml.
    Bangma C
    Nat Clin Pract Urol; 2006 Oct; 3(10):520-1. PubMed ID: 17031372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Legal (liability) aspects of PSA determination].
    Mielke K
    Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
    [No Abstract]   [Full Text] [Related]  

  • 9. New PSA guidelines discourage overscreening.
    Peres J
    J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
    Kuruma H; Egawa S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic specific antigen: role and significance in urologic practice].
    Manolović D; Pejcić T; Milović N
    Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostate-specific antigen in the diagnosis of prostate cancer in Denmark].
    Andreassen LA; Vondeling H
    Ugeskr Laeger; 2006 Jan; 168(5):475-7. PubMed ID: 16472437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Authorities in USA don't recommend screening for prostate cancer].
    Bratt O
    Lakartidningen; 2011 Nov 16-22; 108(46):2362. PubMed ID: 22468374
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer detection: beware of the low PSA.
    Haas GP
    Can J Urol; 2007 Jun; 14(3):3534. PubMed ID: 17594742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management].
    Malmström PU
    Lakartidningen; 2006 Feb 1-7; 103(5):279. PubMed ID: 16512565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pro PSA: a new prostate cancer marker].
    Peyromaure M
    Prog Urol; 2004 Sep; 14(4 Suppl):8-11. PubMed ID: 15776578
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
    Hamilton RJ; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
    [No Abstract]   [Full Text] [Related]  

  • 20. PSA: prostate-specific antigen, persisting scientific ambiguities.
    Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.